Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 11, 2017 - Issue
Submit an article Journal homepage
96
Views
9
CrossRef citations to date
0
Altmetric
Review

Guideline development for the management of gout: role of combination therapy with a focus on lesinurad

Graeme Jones1 Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, AustraliaCorrespondence[email protected]
,
Elena Panova1 Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia
&
Richard Day2 University of New South Wales, Medicine, St Vincent’s Hospital, Sydney, NSW, Australia
Pages 3077-3081 | Published online: 24 Oct 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ettore Marconi, Alessandra Bettiol, Niccolò Lombardi, Giada Crescioli, Luca Parretti, Alfredo Vannacci, Gerardo Medea, Claudio Cricelli & Francesco Lapi. (2019) Prescribing patterns of allopurinol and febuxostat according to directives on the reimbursement criteria and clinical guidelines: analysis of a primary care database. Current Medical Research and Opinion 35:4, pages 683-688.
Read now

Articles from other publishers (8)

Ya-Jia Li, Li-Rong Chen, Zhong-Lei Yang, Ping Wang, Fang-Fang Jiang, Yu Guo, Kai Qian, Mei Yang, Sun-Jun Yin & Gong-Hao He. (2022) Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis. Clinical Rheumatology 42:1, pages 215-224.
Crossref
Danni Song, Xu Zhao, Fuqi Wang & Gang Wang. (2021) A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications. European Journal of Pharmacology 907, pages 174291.
Crossref
Yiming Wang, Weikaixin Kong, Liang Wang, Tianyu Zhang, Boyue Huang, Jia Meng, Baoxue Yang, Zhengwei Xie & Hong Zhou. (2020) Multiple-Purpose Connectivity Map Analysis Reveals the Benefits of Esculetin to Hyperuricemia and Renal Fibrosis. International Journal of Molecular Sciences 21:20, pages 7695.
Crossref
R. Kampe, C. Durme, M. Janssen, Y. Eijk‐Hustings, A. Boonen & T. L. Jansen. (2020) Comparative Study of Real‐Life Management Strategies in Gout: Data From Two Protocolized Gout Clinics. Arthritis Care & Research 72:8, pages 1169-1176.
Crossref
Richard O. Day, Wendy Lau, Sophie L. Stocker, Eindra Aung, Mathew J. Coleshill, Marcel Schulz, Jacob Bechara, Jane E. Carland, Garry G. Graham, Kenneth M. Williams & Andrew J. McLachlan. (2019) Management of gout in older people. Journal of Pharmacy Practice and Research 49:1, pages 90-97.
Crossref
Roland SeifertRoland Seifert. 2019. Basic Knowledge of Pharmacology. Basic Knowledge of Pharmacology 279 286 .
Lili Wu, Yulian Chen, Han Liu, Zhikun Zhan, Zhi Liang, Tao Zhang, Zheng Cai, Ling Ye, Menghua Liu, Jie Zhao, Shuwen Liu & Lan Tang. (2018) Emodin-induced hepatotoxicity was exacerbated by probenecid through inhibiting UGTs and MRP2. Toxicology and Applied Pharmacology 359, pages 91-101.
Crossref
Pascal Heitel, Leonie Gellrich, Jan Heering, Tamara Goebel, Astrid Kahnt, Ewgenij Proschak, Manfred Schubert-Zsilavecz & Daniel Merk. (2018) Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro. Scientific Reports 8:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.